美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Odyssey Therapeutics

19.00

+0.88004.86%

盘后：19.000.00000.00%16:24 EDT

成交量：32.56万

成交额：623.81万

市值：9.13亿

市盈率：-5.69

高：19.65

开：18.72

低：18.49

收：18.12

52周最高：29.05

52周最低：15.10

股本：4,803.13万

流通股本：1,324.00万

量比：1.18

换手率：2.46%

股息：- -

股息率：- -

每股收益(TTM):-3.3410

每股收益(LYR):-50.1297

净资产收益率：-85.50%

总资产收益率：-41.66%

市净率：2.17

市盈率(LYR):-0.38

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Odyssey Therapeutics将在2026年UEG周口头报告Od-001治疗溃疡性结肠炎的额外2a期诱导数据

Odyssey Therapeutics获H.C. Wainwright首予买入评级，目标价定为44美元

美股异动 | Odyssey Therapeutics(ODTX.US)登陆美股市场开盘股价波动不大

生物技术公司Odyssey在美国首次公开募股中募资2.79亿美元，募资规模较原计划有所扩大

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/ODTX"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ODTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODTX\",,,,,undefined,":{"symbol":"ODTX","market":"US","secType":"STK","nameCN":"Odyssey Therapeutics","latestPrice":19,"timestamp":1791576000000,"preClose":18.12,"halted":0,"volume":325591,"hourTrading":{"tag":"盘后","latestPrice":19,"preClose":19,"latestTime":"16:24 EDT","volume":5394,"amount":102486,"timestamp":1791577465177,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.048565121412803475,"floatShares":13240000,"shares":48031300,"eps":-3.341,"marketStatus":"盘后交易","change":0.88,"latestTime":"10-09 18:14:10 EDT","open":18.72,"high":19.65,"low":18.49,"amount":6238102,"amplitude":0.064018,"askPrice":19.03,"askSize":1,"bidPrice":18.93,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-3.341,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1791590400000},"marketStatusCode":4,"adr":0,"listingDate":1778212800000,"exchange":"NASDAQ","adjPreClose":18.12,"preHourTrading":{"tag":"盘前","latestPrice":19.05,"preClose":18.12,"latestTime":"09:18 EDT","volume":142,"amount":2714.09996,"timestamp":1791551932761,"change":0.93,"changeRate":0.051325,"amplitude":0.059051},"postHourTrading":{"tag":"盘后","latestPrice":19,"preClose":19,"latestTime":"16:24 EDT","volume":5394,"amount":102486,"timestamp":1791577465177,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.176758},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODTX\",,,,,undefined,":{"symbol":"ODTX","floatShares":13240000,"roa":"-41.66%","roe":"-85.50%","lyrEps":-50.129685,"volumeRatio":1.176758,"shares":48031300,"dividePrice":0,"high":19.65,"amplitude":0.064018,"preClose":18.12,"low":18.49,"week52Low":15.1,"pbRate":"2.17","psRate":"9218.13","week52High":29.05,"institutionHeld":0,"latestPrice":19,"eps":-3.341,"divideRate":0,"volume":325591,"delay":0,"ttmEps":-3.341,"open":18.72,"prevYearClose":18,"prevWeekClose":20.725,"prevMonthClose":22.22,"prevQuarterClose":22.22,"fiveDayClose":20.725,"twentyDayClose":24.63,"sixtyDayClose":17.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ODTX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODTX","date":"2026-10-08","current":-5.68692,"percent":0.836538,"low":-8.61189,"twenty":-6.929038,"median":-5.955971,"eighty":-5.4285,"high":-5.017591,"avg":-6.165306,"sd":0.813997,"marketCap":866365738},"quantilePoints":[{"date":"2026-05-08","current":-5.722186,"twenty":-5.722186,"median":-5.722186,"eighty":-5.722186,"marketCap":850585842},{"date":"2026-05-15","current":-5.496622,"twenty":-5.693383,"median":-5.609284,"eighty":-5.496622,"marketCap":817056381},{"date":"2026-05-22","current":-5.629912,"twenty":-5.680689,"median":-5.537878,"eighty":-5.38396,"marketCap":836869527},{"date":"2026-05-29","current":-5.687036,"twenty":-5.681958,"median":-5.553746,"eighty":-5.441085,"marketCap":845360875},{"date":"2026-06-05","current":-5.395068,"twenty":-5.640067,"median":-5.507729,"eighty":-5.381104,"marketCap":801960652},{"date":"2026-06-12","current":-5.33477,"twenty":-5.599446,"median":-5.433151,"eighty":-5.365236,"marketCap":792997562},{"date":"2026-06-18","current":-5.864756,"twenty":-5.646414,"median":-5.455366,"eighty":-5.369045,"marketCap":871778402},{"date":"2026-06-26","current":-5.739918,"twenty":-5.704904,"median":-5.528358,"eighty":-5.374757,"marketCap":852228560},{"date":"2026-07-02","current":-5.356182,"twenty":-5.790223,"median":-5.545812,"eighty":-5.374122,"marketCap":795253729},{"date":"2026-07-10","current":-5.427125,"twenty":-5.732825,"median":-5.496622,"eighty":-5.359042,"marketCap":805786891},{"date":"2026-07-17","current":-5.501292,"twenty":-5.710665,"median":-5.510065,"eighty":-5.36714,"marketCap":816798833},{"date":"2026-07-24","current":-5.697997,"twenty":-5.732825,"median":-5.553746,"eighty":-5.374122,"marketCap":846004419},{"date":"2026-07-31","current":-5.939848,"twenty":-5.856557,"median":-5.572788,"eighty":-5.377217,"marketCap":881912925},{"date":"2026-08-07","current":-6.447481,"twenty":-5.942427,"median":-5.59659,"eighty":-5.382058,"marketCap":1031771093},{"date":"2026-08-14","current":-6.204393,"twenty":-6.026914,"median":-5.668975,"eighty":-5.382691,"marketCap":992870470},{"date":"2026-08-21","current":-7.387181,"twenty":-6.093162,"median":-5.678649,"eighty":-5.386182,"marketCap":1182148383},{"date":"2026-08-28","current":-7.779447,"twenty":-6.206789,"median":-5.687036,"eighty":-5.395703,"marketCap":1244921564},{"date":"2026-09-04","current":-7.905212,"twenty":-6.445274,"median":-5.710091,"eighty":-5.402083,"marketCap":1265047317},{"date":"2026-09-11","current":-7.078758,"twenty":-6.638581,"median":-5.780226,"eighty":-5.417451,"marketCap":1132792370},{"date":"2026-09-18","current":-6.952993,"twenty":-6.952993,"median":-5.846332,"eighty":-5.42363,"marketCap":1112666617},{"date":"2026-09-25","current":-5.967836,"twenty":-6.988926,"median":-5.907601,"eighty":-5.427125,"marketCap":955014887},{"date":"2026-10-02","current":-6.114561,"twenty":-6.952993,"median":-5.955971,"eighty":-5.433151,"marketCap":978494932},{"date":"2026-10-08","current":-5.413872,"twenty":-6.929038,"median":-5.955971,"eighty":-5.4285,"marketCap":866365738}],"updateTime":1791584050536},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ODTX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1192452675","title":"Odyssey Therapeutics将在2026年UEG周口头报告Od-001治疗溃疡性结肠炎的额外2a期诱导数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1192452675","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192452675?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 20:01","pubTimestamp":1791288073,"startTime":"0","endTime":"0","summary":"Odyssey Therapeutics宣布，将在2026年UEG周上以口头报告形式公布Od-001用于溃疡性结肠炎的额外2a期诱导数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117139045","title":"Odyssey Therapeutics获H.C. Wainwright首予买入评级，目标价定为44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117139045","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117139045?lang=zh_cn&edition=fundamental","pubTime":"2026-08-27 18:13","pubTimestamp":1787825595,"startTime":"0","endTime":"0","summary":"Odyssey Therapeutics公司今日迎来重要机构关注——H.C. Wainwright正式启动对该公司的覆盖研究，并给予“买入”评级。与此同时，该机构设定其目标价格为每股44美元。这一举动不仅彰显了市场对Odyssey Therapeutics发展潜力的认可，也为投资者提供了新的参考依据。作为一家备受瞩目的生物医药企业，Odyssey Therapeutics此番获得积极评价，或将在资本市场引发新一轮关注热潮。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634465519","title":"美股异动 | Odyssey Therapeutics(ODTX.US)登陆美股市场 开盘股价波动不大","url":"https://stock-news.laohu8.com/highlight/detail?id=2634465519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634465519?lang=zh_cn&edition=fundamental","pubTime":"2026-05-09 00:00","pubTimestamp":1778256000,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Odyssey Therapeutics(ODTX.US)登陆美股市场，开盘股价波动不大，IPO价格为18美元。截至发稿，该股跌超1%，报17.81美元。Odyssey Therapeutics是一家总部位于美国波士顿的临床阶段生物科技公司，主要专注于自身免疫性及炎症性疾病药物研发。公司核心产品为OD-001，这是一款用于治疗溃疡性结肠炎的小分子药物，目前已进入中期临床试验阶段。此外，公司还布局红斑狼疮、特应性皮炎等多个免疫疾病管线。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","ODTX","BK4007","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633101148","title":"生物技术公司Odyssey在美国首次公开募股中募资2.79亿美元，募资规模较原计划有所扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2633101148","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633101148?lang=zh_cn&edition=fundamental","pubTime":"2026-05-08 08:52","pubTimestamp":1778201535,"startTime":"0","endTime":"0","summary":"生物技术公司Odyssey在美国首次公开募股中募资2.79亿美元，募资规模较原计划有所扩大路透5月8日 - 生物制药公司奥德赛治疗（Odyssey Therapeutics，股票代码：ODTX.O）周四表示，其在美国的首次公开募股（IPO）规模已扩大，共筹集资金2.79亿美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL4T41L022:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ODTX\",params:#limit:6,delay:false,,,undefined,":[]}}